RXQ has been backed by Ohio Innovation Fund as it prepares to build beyond its current location at the Ohio University Innovation Center.
RXQ Compounding, a US-based drug compound manufacturer based at Ohio University’s Innovation Center, raised a series A sum of undisclosed size on Monday in a round led by the Ohio Innovation Fund.
Founded in 2014, RXQ manufactures a range of more than 140 pharmaceutical products that include injectables, veterinary medications and dermatological creams or ointments, as well as ophthalmic solutions, orthopaedic steroids and custom lines for hospitals.
The manufacturing process is marketed as being fully compliant with the standards of…
